Gene therapy trial for cystic fibrosis shows modest benefits

Click for article

Click for article

A gene therapy trial has shown a small but notable health benefit in people with cystic fibrosis—proof of principle that, after a long wait, hopes of effective treatments for inherited diseases may one day be realised.

In a trial involving 136 cystic fibrosis patients aged over 12 who used nebulisers to inhale the correct gene wrapped in an envelope of fat, modest benefits were observed over a range of measurements when compared with patients inhaling a placebo. The main aim was to show that the treatment, given monthly for a year, would improve lung function measured by the volume of air the patients could expel in one second.

NICE Community: March 2013 – Top guidance trends

nice_logoTop Guidance Trends

  • Hypertension: CG127
  • Type 2 diabetes (partially updated by CG87): CG66
  • Intrapartum care: CG55
  • Hypertension: QS28